ginseng
Botanicalexperimental
Panax notoginseng is a species of the genus Panax, and it is commonly referred to in English as Chinese ginseng or notoginseng. In Chinese it is called tiánqī, tienchi ginseng, sānqī or sanchi, three-seven root, and mountain plant. P. notoginseng belongs to the same scientific genus as Panax ginseng. In Latin, the word panax means "cure-all", and the family of ginseng plants is one of the best-known herbs. — Wikipedia
Clinical trial activity
121 trials · 137 clinical orgs · 0 marketing orgs
Phase 1
18
Phase 2
39
Phase 3
22
Phase 4
12
Earliest trial started Mar 1, 1998 (NCT02923453)
Timeline
Indications
Approved for
Studied for
- Acute Coronary Syndrome · Phase 3
- Altitude Sickness · Phase 3
- Alzheimer Disease · Phase 1/Phase 2
- Angina Pectoris · Phase 3
- Atherosclerosis · Phase 4
- Blood Pressure · Phase 2
- Bone Diseases, Metabolic · Phase 2/Phase 3
- Brain Waves · Phase 4
- Breast Neoplasms · Phase 3
- Cancer Survivors · Early Phase 1
- Cognition · Early Phase 1
- Colonic Neoplasms · Early Phase 1
- Colorectal Neoplasms · Phase 2
- Community-Acquired Infections · Phase 3
- COVID-19 · Phase 2/Phase 3
- Diabetes Mellitus · Phase 4
- Diabetes Mellitus, Type 2 · Phase 2/Phase 3
- Endothelium · Phase 2
- Fatigue · Phase 4
- Fatigue Syndrome, Chronic · Phase 3
- Fibromyalgia · Early Phase 1
- Healthy Aging · Phase 2/Phase 3
- Healthy Volunteers · Phase 4
- Hematoma · Phase 4
- Herbal Medicine · Phase 2/Phase 3
- HIV Infections · Phase 2
- Hyperglycemia · Phase 3
- Hyperlipidemias · Phase 2
- Hypersensitivity · Phase 4
- Hypertension · Phase 3
- Hypotension · Phase 2/Phase 3
- Immune System Diseases · Phase 4
- Infertility, Male · Phase 4
- Insulin Resistance · Phase 1/Phase 2
- Ischemic Stroke · Phase 4
- Leukemia · Phase 3
- Leukemia, Lymphocytic, Chronic, B-Cell · Phase 1
- Lymphoma · Phase 3
- Lymphoproliferative Disorders · Phase 3
- Malabsorption Syndromes · Phase 1
- Memory Disorders · Phase 3
- Metabolic Syndrome · Phase 1
- Multiple Myeloma · Phase 3
- Multiple Sclerosis · Phase 2
- Myelodysplastic Syndromes · Phase 3
- Myeloproliferative Disorders · Phase 3
- Neoplasms · Phase 3
- Neoplasms, Second Primary · Phase 2
- Obesity · Phase 2/Phase 3
- Oxidative Stress · Phase 2/Phase 3
- Palliative Care · Phase 2
- Palliative Medicine · Phase 2
- Precancerous Conditions · Phase 3
- Prehypertension · Phase 3
- Psychological Distress · Phase 3
- Psychotic Disorders · Phase 1/Phase 2
- Respiratory Tract Infections · Phase 3
- Schizophrenia · Phase 1/Phase 2
- Sports Medicine · Early Phase 1
- Sprains and Strains · Phase 1
- Stress, Psychological · Phase 1/Phase 2
- Tardive Dyskinesia · Phase 1/Phase 2
- Xerostomia · Phase 4
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPanax notoginseng ↗
- NCATSF055A23N6X ↗
- WikipediaGinsenoside ↗
- NCATSCUQ3A77YXI ↗
Also known as
- afx-2
- american ginseng extract
- aralia ginseng root
- asian ginseng
- asian ginseng root
- chinese ginseng root
- cold-fx
- cvt e002
- cvt-e002
- cvt-e002
- fermented ginseng
- fermented red ginseng
- fermented-red ginseng
- fructus schizandrae - radix ginseng - radix ophiopogonis
- fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
- ginseng
- ginseng
- ginseng
- ginseng
- ginseng, asian
- ginseng extract
- ginseng (panax ginseng)
- ginseng polysaccharide extract
- ginsenoside
- ginsenoside
- ginseol kg1
- hong shen root
- hydrolyzed ginseng extract
- insam root
- korean ginseng
- korean ginseng root
- korean red ginseng
- ninjin root
- panax
- panax
- panax ginseng
- panax ginseng
- panax ginseng root
- panax ginseng root extract
- panax notoginseng
- panax notoginseng saponins
- panax notoginseng saponins
- panax schinseng root
- panax verus root
- radix notoginseng
- red ginseng
- red ginseng
- red ginseng extracts
- ren seng root
- ren shen
- ren shen root
- ren shen yang rong tang
- sheng mai
- shengmaisan
- sheng-mai-san
- sheng-mai-yin
- shenmai
- shenmai
- shen mai
- true ginseng root
- white korean ginseng
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07255755 | N/A | Dec 1, 2025 | Atlantia Food Clinical Trials, University of East Anglia |
| NCT07081802 | N/A | Aug 1, 2025 | China Academy of Chinese Medical Sciences, Dalian Medical University, Handan Central Hospital, Hebei University, Nanchang University, The First Hospital of Qinhuangdao |
| NCT07127705 | N/A | May 21, 2025 | Natural Immune Systems Inc |
| NCT06845254 | Phase 3 | Mar 1, 2025 | China Academy of Chinese Medical Sciences |
| NCT06618495 | Phase 1/Phase 2 (Phase 2) | Oct 13, 2024 | China Academy of Chinese Medical Sciences |
| NCT06395441 | Phase 3 | Aug 1, 2024 | Mayo Clinic |
| NCT06236243 | N/A | Jan 31, 2024 | Korea Ginseng Corporation, Nutrasource Diagnostics |
| NCT06214195 | Phase 3 | Jan 20, 2024 | Chinese Academy of Medical Sciences |
| NCT06167902 | N/A | Dec 25, 2023 | Chinese Academy of Medical Sciences |
| NCT07252362 | N/A | Nov 11, 2023 | Chinese Academy of Medical Sciences |
| NCT05664009 | Phase 2 | Dec 31, 2022 | Canada Royal Enoch Phytomedicine Co., Ltd., KGK Science Inc. |
| NCT05592093 | Phase 2/Phase 3 (Phase 3) | Dec 20, 2022 | Capital Medical University, Jiao Tong University |
| NCT05241405 | N/A | Sep 27, 2022 | Groupement Interrégional de Recherche Clinique et d'Innovation Est, University of Caen-Normandie |
| NCT05480774 | Phase 1 | Aug 6, 2022 | Hanoi Medical University, Inno.N, Kyung Hee University |
| NCT05227313 | N/A | Mar 1, 2022 | Tzu Chi University |
| NCT05725044 | N/A | Dec 13, 2021 | Amorepacific Corporation, Inha University |
| NCT04932265 | Phase 1 | Sep 30, 2021 | EuroPharma, Inc., Government of Armenia, Institute of Fine Organic Chemistry of the National Academy of Science, Armenia, Institute of Fine Organic Chemistry of the National Academy of Science Yerevan, Armenia, Phytomed AB |
| NCT05055427 | Phase 2/Phase 3 (Phase 3) | Aug 20, 2021 | Ho Chi Minh City University of Medicine and Pharmacy |
| NCT04993729 | Phase 3 | Jul 21, 2021 | Tasly Pharmaceuticals, Inc., University of California, San Francisco |
| NCT04940117 | N/A | Jul 1, 2021 | Kaohsiung Medical University, WU SAM-CHIANG Medical clinic |
Showing 20 of 121 trials
Page 1 / 7
Organizations
Research & Development (137)
137 organizations
Page 1 / 7